Prostate cancer: Increased dementia risk following androgen deprivation therapy?
Nature Publishing Group
School of Medical Sciences / Centre of Excellence for Alzheimer's Disease Research and Care
Although the increased use of androgen deprivation therapy for prostate cancer might be improving survival, a recent large retrospective cohort study that analysed hospital medical record data indicates that long therapy duration is associated with an increased risk of Alzheimer's disease.
Not open access